{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-038331","form_type":"8-K","ticker":"OWLT","cik":"0001816708","company_name":"Owlet, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.628541+00:00","generated_at":"2026-06-08T07:25:38.977240+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Owlet receives FDA de novo clearance for Dream Sock as first OTC infant pulse oximeter","bullets":["FDA-cleared Dream Sock monitors pulse rate and oxygen saturation for healthy infants 1-18 months, 6-30 lbs.","Device provides Health Notifications with lights and alarms when readings fall outside preset ranges.","Medical-grade features to roll out to existing and new Dream Sock users by end of 2023 (U.S. only).","Follows prior FDA clearance of prescription BabySat system; Dream Sock now available without prescription.","CEO calls it a 'significant breakthrough' in at-home infant care and commitment to innovation."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-038331","json":"https://secwatch.observer/filing/0001628280-23-038331.json","markdown":"https://secwatch.observer/filing/0001628280-23-038331.md","text":"https://secwatch.observer/filing/0001628280-23-038331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816708/000162828023038331/0001628280-23-038331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816708/000162828023038331/owlt-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:25:38.977240+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}